Learning tumour language: Neovivum’s role in predicting cancer resistance
Current precision oncology faces a fundamental limitation. While doctors can identify biomarkers that correlate with treatment response, they cannot model how tumours adapt when th
Meet the CSIC team contributing expertise in tumour microenvironment analysis
The Spanish National Research Council (CSIC), through the Institute of Advanced Chemistry of Catalonia (IQAC) is contributing to the CancerScan project through its expertise in tum
Politecnico di Milano Joins CancerScan to Advance Precision Oncology through Digital Twins
Politecnico di Milano is part of CancerScan, the EU project shaping the future of precision oncology through tumour digital twins. Led by Marco Santambrogio and Davide Conficconi,
Predicting therapy resistance in tissue slides: a reminder of AI’s power in cancer image analysis
In 2020, widely read outlets such as Scientific American highlighted a striking achievement: Google’s artificial intelligence (AI) system could outperform clinicians in detecting
CancerScan kicks off to advance personalised cancer treatment in Europe
The CancerScan kick-off meeting successfully took place on the 16th of September 2025, bringing together the project partners to officially launch the three-year initiative. During